HIV Testing Supplementary Consultation
Hello Dr.
Hong, thank you for your response during the holiday.
Based on your previous reply, I would like to ask the following questions: (1) Is HIV-0 not an independent type, but rather a subtype of HIV-1 (HIV-1 subtype 0)? (2) Is HIV-0 (HIV-1 subtype 0) prevalent in Taiwan, Asia, or mainland China? Given that testing reagents may not cover all variants, should we be concerned about HIV-0 (HIV-1 subtype 0)? (3) Are HIV-1 O and HIV-0 (HIV-1 subtype 0) different types? I apologize for the inconvenience and appreciate your time in answering these questions.
Thank you.
JJ, 30~39 year old female. Ask Date: 2020/10/02
Dr. Hong Yuanbin reply Internal Medicine
Hello,
1.
HIV-0 usually refers to HIV-1 subtype O; however, there is currently limited research literature on this topic in Taiwan or Asia, so its prevalence rate cannot be determined at this time.
2.
As for whether the reagents can detect it, that depends on the reports for each specific reagent.
3.
I'm not sure what you mean by HIV-1 O.
It could refer to a genotype, or it might mean "patient zero," or it could have other meanings.
Thank you for your inquiry.
Reply Date: 2020/10/02
More Info
Understanding HIV-1 Subtype O is crucial for both public health and individual health management, especially in regions like Taiwan and Asia where the prevalence of different HIV subtypes can vary significantly. Let’s address your questions systematically.
1. HIV-0 as a Subtype of HIV-1: Yes, HIV-0 is indeed classified as a subtype of HIV-1, specifically referred to as HIV-1 subtype O. This subtype was first identified in the early 1990s and is primarily found in West and Central Africa. It is important to note that while HIV-0 is a recognized subtype, it is not as prevalent as other subtypes like HIV-1 subtype B or C.
2. Prevalence of HIV-0 in Taiwan and Asia: The prevalence of HIV-1 subtype O in Taiwan, Asia, and mainland China is relatively low. Most of the HIV infections in these regions are caused by HIV-1 subtype B, which is the predominant strain. Research on HIV-0 is limited in these areas, and as such, the exact prevalence rates are not well-documented. However, the risk of encountering HIV-0 in Taiwan is considered low, and most testing protocols are designed to detect the more common subtypes.
Regarding the concern about testing reagents, it is true that not all HIV tests are designed to detect every subtype. Most standard tests, including the commonly used ELISA and rapid tests, are effective at detecting HIV-1 subtypes A, B, C, D, E, and F, but may have reduced sensitivity for subtypes O and N. Therefore, while the risk of missing an HIV-0 infection is low, it is not zero, particularly if the individual has been exposed to populations where this subtype is more prevalent.
3. Differentiation between HIV-1 O and HIV-0: HIV-1 O and HIV-0 refer to the same subtype. The terminology can sometimes cause confusion, but they are used interchangeably in the context of HIV-1 subtype O. It is essential to understand that while HIV-1 has various subtypes and circulating recombinant forms, the classification helps in understanding the epidemiology and transmission dynamics of the virus.
In terms of testing, if there is a concern about potential exposure to HIV-0, it may be advisable to use more sensitive testing methods such as nucleic acid tests (NAT) or polymerase chain reaction (PCR) tests, which can detect the virus itself rather than relying solely on antibody detection. These methods can provide earlier detection of HIV infection and are particularly useful in cases where there is a suspicion of infection with less common subtypes.
In conclusion, while HIV-1 subtype O is a recognized variant of the virus, its prevalence in Taiwan and surrounding regions is low. Standard HIV testing methods are generally effective, but awareness of the limitations regarding specific subtypes is essential. If there are ongoing concerns about potential exposure or if symptoms arise, it is advisable to consult with a healthcare provider for further evaluation and possibly more sensitive testing. Regular follow-ups and open communication with healthcare professionals can help manage any risks associated with HIV effectively.
Similar Q&A
Understanding HIV Testing: Concerns About Variants and Accuracy
Hello Dr. Hong, I apologize for the interruption. Here is my story: On August 2, 2019, after a gathering with friends, we went to a special location where the female service providers were from Southeast Asia or mainland China. That day, I engaged in unprotected oral sex and prot...
Dr. Hong Yuanbin reply Internal Medicine
Hello, in response to your inquiries, here are a few points: 1. The combo test kits you are using are universally applicable, so there should be no type-related issues even in Southeast Asia; the results should be consistent. 2. Based on your description, you have not engaged...[Read More] Understanding HIV Testing: Concerns About Variants and Accuracy
Understanding Anti-HIV Testing: Key Insights and Recommendations
Hello Dr. Hong, Due to certain needs, I recently went to the municipal hospital to have my blood tested for Anti-HIV after an HIV window period of 84 days. I understand that the Anti-HIV test is an HIV antibody test, and the final test result was <0.05 (with a reference valu...
Dr. Hong Yuanbin reply Internal Medicine
Hello, the ELISA test is used for initial screening for HIV. If the result is positive, a confirmatory Western blot test is performed. If the result is negative, regular follow-up is recommended. Currently, the predominant strains in most countries are HIV-1 and HIV-2, with HIV-2...[Read More] Understanding Anti-HIV Testing: Key Insights and Recommendations
Understanding HIV Window Period in the Context of Hepatitis C Exposure
Hello Dr. Liao, I would like to ask you the following questions: 1. In the context of having hepatitis C, if I have been exposed to a potential risk of HIV infection due to three factors: needlestick injury, skin break with bleeding that came into contact with the bodily fluids...
Dr. Liao Zhongxin reply Internal Medicine
Dear readers: Regarding the question of whether there is a premise of hepatitis C, the response is as follows: I. Referencing the information from the Centers for Disease Control (CDC) website http://www.cdc.gov.tw/professional/info.aspx? (1) Hepatitis C occurs globally. In th...[Read More] Understanding HIV Window Period in the Context of Hepatitis C Exposure
Understanding HIV Testing: Can PCR and ELISA Detect All Subtypes?
Hello Dr. Hong, I found that HIV-1 can be divided into groups M, O, and N, with group M further divided into many subtypes. I have currently performed RT-PCR and an ELISA combo test. I would like to ask if both PCR and ELISA can accurately screen for groups M, N, O, and the subty...
Dr. Hong Yuanbin reply Internal Medicine
Hello, most major hospitals currently use PCR or Combo tests that can detect the subtypes you mentioned. Thank you for your inquiry.[Read More] Understanding HIV Testing: Can PCR and ELISA Detect All Subtypes?
Related FAQ
(Internal Medicine)
Hiv Test(Internal Medicine)
Hiv Screening(Internal Medicine)
Hiv Transmission(Internal Medicine)
Rapid Hiv Test(Internal Medicine)
Hiv Testing(Urology)
Human Immunodeficiency Virus(Urology)
Hiv(Family Medicine)
Std Screening(Internal Medicine)
Needlestick(Internal Medicine)